By voluntarily self-disclosing the violations and cooperating with the DOJ, the testing laboratory avoided open-ended exposure, a corporate integrity agreement, and exclusion from federal programs.
By voluntarily self-disclosing the violations and cooperating with the DOJ, the testing laboratory avoided open-ended exposure, a corporate integrity agreement, and exclusion from federal programs.
HHS-OIG reminds the healthcare industry that meeting the requirements of the Stark Law or paying fair market value for services doesn’t necessarily satisfy obligations under the federal AKS.
Our in-brief, biweekly roundup of notable DOJ False Claims Act cases related to healthcare fraud.
The complaint alleges a scheme to provide unnecessary medical care to increase Medicare payouts.